| Product Code: ETC6357526 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Malaria Vaccine Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Malaria Vaccine Market - Industry Life Cycle |
3.4 Belgium Malaria Vaccine Market - Porter's Five Forces |
3.5 Belgium Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Belgium Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Belgium Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Belgium Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Belgium Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in Belgium |
4.2.2 Government initiatives and funding for malaria prevention and control |
4.2.3 Growing awareness among healthcare professionals and the general public about the importance of malaria vaccination |
4.3 Market Restraints |
4.3.1 High cost of malaria vaccines |
4.3.2 Limited access to healthcare services in certain regions of Belgium |
4.3.3 Potential side effects or safety concerns associated with malaria vaccines |
5 Belgium Malaria Vaccine Market Trends |
6 Belgium Malaria Vaccine Market, By Types |
6.1 Belgium Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Belgium Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Belgium Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Belgium Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Belgium Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Belgium Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Belgium Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Belgium Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Belgium Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Belgium Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Belgium Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Belgium Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Belgium Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Belgium Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Belgium Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Belgium Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Belgium Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Belgium Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Belgium Malaria Vaccine Market Export to Major Countries |
7.2 Belgium Malaria Vaccine Market Imports from Major Countries |
8 Belgium Malaria Vaccine Market Key Performance Indicators |
8.1 Number of malaria cases reported in Belgium annually |
8.2 Percentage of healthcare professionals recommending malaria vaccination |
8.3 Government spending on malaria prevention programs in Belgium |
9 Belgium Malaria Vaccine Market - Opportunity Assessment |
9.1 Belgium Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Belgium Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Belgium Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Belgium Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Belgium Malaria Vaccine Market - Competitive Landscape |
10.1 Belgium Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Belgium Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here